Objectives To evaluate the risk of venous thromboembolic events associated with the use of
progestin-only contraception and whether that risk differs with the mode of drug delivery …

Estrogen-containing medication, prescribed either for contraception in women of
reproductive age or for prevention of cardiovascular events and osteoporosis as well as for …

Abstract In a 1994–1998 cross-sectional study of a multiethnic sample of 2,211 men and
women in San Diego, California, the authors estimated prevalence of the major …

Cardiovascular disease is emerging as a cardinal trait of Turner syndrome, being
responsible for half of the 3-fold excess mortality. Turner syndrome has been proposed as …

Background: Pulmonary embolism (PE) is a leading cause of death following gastric bypass
operations for morbid obesity. Although its incidence appears to be stable, the number of …

Background Postmenopausal hormone therapy has been associated with a 2-to 3-fold
increased risk of venous thromboembolism (VT)(including deep vein thrombosis and …

Venous thromboembolism is a serious disorder because of its potential complications, such
as pulmonary embolism and the post-thrombotic syndrome. Inherited determinants of …

Single-point mutations in the gene coding for prothrombin (factor II: A20210) or factor V
(factor V: A1691) are associated with an increased risk of venous thromboembolism. The …

Haemorheological variables (whole‐blood, plasma and relative blood viscosity, haematocrit,
red cell aggregation, white cell count and fibrinogen) were measured in 753 men and 821 …

Hormone replacement therapy (HRT) has been shown to increase the relative risk of
idiopathic venous thromboembolism (VTE) about threefold in several observational studies …